Skip to content

Author

Carlos A. Zarate

4 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Brain network-driven predictive neural markers for suicide risk

Background Suicide is a significant public health challenge, underscoring the need for temporally precise and objective biomarkers to identify acute suicide risk. One potential biomarker is electrophysiological brain connectivity measured by magnetoencephalography (MEG). This study used publicly available atlases to es...

Yoojin Lee, Jessica R. Gilbert, Cherise R. Chin Fatt et al. · 0 citations
Open access Sep 2026

Treatments for Individuals with Suicidal Thoughts: Use, Indications, and Helpfulness

Background: Although millions of adults seriously consider suicide each year, clinical trials often exclude individuals experiencing suicidal ideation (SI). This analysis sought to describe the use of a range of psychiatric treatment modalities in individuals with mood disorders with and without a history of suicide at...

Elizabeth D. Ballard, Halla Hafermann, Kelly T. Hurst et al. · 0 citations
Open access Sep 2026

Plasma copeptin is coupled to resting-state frontoinsular-subgenual alpha dynamics in major depression with comorbid post-traumatic stress disorder

Background Hypothalamic-pituitary-adrenal axis dysregulation is implicated in depression and post-traumatic stress disorder (PTSD), but stress-related neuroendocrine mechanisms that distinguish their comorbid presentation remain poorly understood. Prior work in the broader parent cohort found lower levels of plasma cop...

Hiroe Hu, Benjamin H. Chandler, J. Sloane et al. · 0 citations
Review Open access Sep 2026

Modulation of GABA and Glutamate by Ketamine in Depression: A Systematic Review and Meta-Analysis of Magnetic Resonance Spectroscopy Studies

Rigorous RCTs with standardized protocols, larger sample sizes, uniform dosing, and systematic biomarker investigations are needed to clarify ketamine’s neurochemical mechanism and optimize ketamine’s clinical application in treatment-resistant depression.

Balwinder Singh, Hossam M. Ali, Alessandro Miola et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.